{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Jin R"],"funding":["Haiyan Foundation of Harbin Medical University Cancer Hospital","Medical Wisdom Research Fund by the Heilongjiang Sunshine Health Foundation","Nn10 project of Harbin medical university cancer hospital","Beijiing Yanchuang Foundation"],"pagination":["427-442"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11748461"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["197(1)"],"pubmed_abstract":["IGFLR1 is a novel biomarker, and some evidences suggested that is involved in the immune microenvironment of CRC. Here, we explored the expression of IGFLR1 and its association with the prognosis as well as immune cell infiltration in CRC, with the aim to provide a basis for further studies on IGFLR1. Immunohistochemical staining for IGFLR1, TIM-3, FOXP3, CD4, CD8, and PD-1 was performed in eligible tissues to analyze the expression of IGFLR1 and its association with prognosis and immune cell infiltration. Then, we screened colon cancer samples from TCGA and grouped patients according to IGFLR1-related genes. We also evaluated the co-expression and immune-related pathways of IGFLR1 to identify the potential mechanism of it in CRC. When P < 0.05, the results were considered statistically si"],"journal":["Applied biochemistry and biotechnology"],"pubmed_title":["Prognostic Value of Insulin Growth Factor-Like Receptor 1 (IGFLR1) in Stage II and III Colorectal Cancer and Its Association with Immune Cell Infiltration."],"pmcid":["PMC11748461"],"funding_grant_id":["H21L0802","ZLKY-20211129-02","JJZD2022-17","no.04000079"],"pubmed_authors":["Xia Y","Liu Y","Guo J","Jin R","Du F","Tong J","Han X","Yang D","Song W","Yue X","Zhang Q"],"additional_accession":[]},"is_claimable":false,"name":"Prognostic Value of Insulin Growth Factor-Like Receptor 1 (IGFLR1) in Stage II and III Colorectal Cancer and Its Association with Immune Cell Infiltration.","description":"IGFLR1 is a novel biomarker, and some evidences suggested that is involved in the immune microenvironment of CRC. Here, we explored the expression of IGFLR1 and its association with the prognosis as well as immune cell infiltration in CRC, with the aim to provide a basis for further studies on IGFLR1. Immunohistochemical staining for IGFLR1, TIM-3, FOXP3, CD4, CD8, and PD-1 was performed in eligible tissues to analyze the expression of IGFLR1 and its association with prognosis and immune cell infiltration. Then, we screened colon cancer samples from TCGA and grouped patients according to IGFLR1-related genes. We also evaluated the co-expression and immune-related pathways of IGFLR1 to identify the potential mechanism of it in CRC. When P < 0.05, the results were considered statistically si","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan","modification":"2025-04-04T20:56:23.066Z","creation":"2025-04-04T20:56:23.066Z"},"accession":"S-EPMC11748461","cross_references":{"pubmed":["39141178"],"doi":["10.1007/s12010-024-05006-1"]}}